stars 1 stars 2 stars 3

MINAKEM is a fully integrated development partner and commercial manufacturer for pharmaceutical companies. - API manufacturing (Innovators/Generics and Highly Potent) - Custom development (process development and optimization) - Custom manufacturing - Production of Key intermediates and building blocks All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state of the art analytical services including solid form and QBD laboratories. MINAKEM’s talented team also ensures high-quality services in Quality Assurance, Regulatory Affairs, Safety, Health and Environment (SHE). Minakem is a technology-driven company with expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, halogenation chemistry, steroid chemistry and “prazole” chemistry… Minakem has operations in 3 different sites, which are all US FDA and local health agencies approved and is : - Dunkirk, France – former AstraZeneca “prazoles” and budesonide production site - Beuvry-la-Forêt, France - Louvain-la-Neuve, Belgium – former Ajimonoto-Omnichem site, specialized in vinca alkaloids synthesis - Montréal , Canada - former Delmar site Strong synergies within MINAKEM facilities sites offer customers the flexibility, responsiveness and cost-effectiveness paired with the strong technical know-how to create significant added value within our customers’ supply chains. Minakem is part of the Minafin Group (link to Minafin site), and as such has access to all technologies, resources, and capabilities to respond to its client’s needs, especially with Leuna, Germany, and Pennakem (USA).

Website http://www.minakem.com
Revenue $185.7 million
Employees 360 (214 on RocketReach)
Founded 2004
Address 145 Chemin Des Lilas, Beuvry la Forêt, Hauts de France 59310, FR
Phone +33 3 20 64 68 30
Technologies
Industry Chemical Manufacturing, Pharmaceuticals, Biotechnology, Specialty Chemicals, API manufacturing, Healthcare, Science and Engineering, Other Chemicals and Gases, Custom development, Life Science, Custom manufacturing, Pharmaceutical, Key intermediates, Health Care, Building blocks, Complex multi-steps synthesis, Chiral synthesis, Steroid, Prazoles, Halogenation, Pressure chemistry, Innovators APIs, Generics APIs, Highly Potent APIs, Excipients
Web Rank 8 Million
Keywords Pharmaceutical Manufacturing, Api Manufacturing, Custom Synthesis, Contract Development And Manufacturing, Process Development, Cdmo, Drug Development, Pharmaceutical Development, Custom Manufacturing, Api Production, Drug Production, Contract Manufacturing, Development Partner, Commercial Manufacturing, Process Optimization, Generic Drugs, Pharmaceutical Ingredients
Competitors Thermo Fisher Scientific, Pfizer, Bristol Myers Squibb, BASF, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, Lonza, SABIC, Evonik, NantPharma +46 more (view full list)
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies

MINAKEM Questions

The MINAKEM annual revenue was $185.7 million in 2026.

Olivier Ubrich is the CEO of MINAKEM.

214 people are employed at MINAKEM.

MINAKEM is based in Beuvry la Forêt, Hauts de France.

The NAICS codes for MINAKEM are [32, 32541, 3254, 325].

The SIC codes for MINAKEM are [28, 283].

Top MINAKEM Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users